Lupus Science and Medicine Podcast
By BMJ Group
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by BMJ Group
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 17
Reviews: 0
Episodes: 48
Description
Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus.
| Episode | Date |
|---|---|
|
Use of Artificial Intelligence and Machine Learning in Clinical Practice
|
May 06, 2024 |
|
To RNase or Not to RNase: That Is the Question
|
Mar 04, 2024 |
|
A decision-aid facilitates patient understanding of benefits vs. risk of hydroxychloriquine use as part of routine care for lupus
|
Feb 05, 2024 |
|
Dual dsDNA testing may be needed to fully understand patient disease status
|
Jan 01, 2024 |
|
Is Anifrolumab an effective treatment for lupus nephritis?
|
Dec 04, 2023 |
|
Which one is better at controlling lupus: Belimumab or Anifrolumab?
|
Nov 07, 2023 |
|
Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis
|
Oct 02, 2023 |
|
Testing a new measure of lupus improvement that encompasses the patients’ perspectives and doctors’ evaluations
|
Sep 04, 2023 |
|
Understanding Lupus: Exploring the Differences between Type 1 and Type 2 Symptoms
|
Aug 07, 2023 |
|
Unpacking Lupus Treatment: How Quickly Does Anifrolumab Start Working? Insights from TULIP Trials
|
Jul 03, 2023 |
|
Biomarker reduction indicates treatment response to Belimumab
|
May 24, 2023 |
|
Mesenchymal stromal cells: a potential new SLE treatment option?
|
Aug 02, 2022 |
|
Using patient registries to estimate SLE incidence rate in the USA
|
May 26, 2022 |
|
Defining remission in systemic lupus erythematosus
|
May 26, 2022 |
|
What’s the relationship between self-efficacy and quality of life in SLE patients?
|
Apr 28, 2022 |
|
Challenging but achievable: reaching Low Lupus Disease Activity State (LLDAS) in childhood-onset SLE
|
Apr 06, 2022 |
|
Could a high fiber diet positively impact the gut microbiome of SLE patients?
|
Feb 24, 2022 |
|
A new biomarker for cognitive dysfunction in SLE?
|
Jan 27, 2022 |
|
Screening for cognitive dysfunction in SLE patients
|
Dec 21, 2021 |
|
Highlights of ACR Convergence 2021
|
Nov 23, 2021 |
|
Personalised metabolite monitoring during pre-conception and pregnancy in SLE patients
|
Nov 17, 2021 |
|
Can you predict lupus nephritis outcomes using machine learning models?
|
Oct 22, 2021 |
|
Highlights of the LUPUS & CORA 2021 joint congress
|
Oct 13, 2021 |
|
Identifying therapeutic targets in lupus nephritis: is obtaining research tissue via biopsy safe?
|
Oct 01, 2021 |
|
LSM’s first Journal Impact Factor™
|
Aug 31, 2021 |
|
Can you conduct clinical trials on lupus patients in a home setting?
|
Jul 02, 2021 |
|
EULAR 2021 eCongress Highlights
|
Jun 08, 2021 |
|
Safety profile of anifrolumab in SLE patients
|
Jun 01, 2021 |
|
The ALPHA Project
|
May 04, 2021 |
|
Lupus Academy 10th Annual Meeting Highlights
|
Apr 22, 2021 |
|
Lupus Academy Tenth Annual Meeting Preview
|
Apr 08, 2021 |
|
Apolipoprotein L1 risk genotypes in Ghanaian patients
|
Apr 06, 2021 |
|
Anti-Müllerian hormone in African- American women with SLE
|
Mar 03, 2021 |
|
Efficacy and safety of rituximab biosimilar in refractory lupus
|
Feb 04, 2021 |
|
Metabolic syndrome in SLE patients
|
Jan 06, 2021 |
|
Validating the use of LFA-REAL to measure disease severity in SLE
|
Dec 16, 2020 |
|
ANA testing in SLE and autoimmune rheumatic diseases
|
Nov 30, 2020 |
|
Kynurenine pathway is altered in patients with SLE and associated with severe fatigue
|
Sep 02, 2020 |
|
TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus
|
Aug 05, 2020 |
|
Lupus Science & Medicine: what makes it special?
|
Jul 07, 2020 |
|
Anifrolumab effects on rash and arthritis
|
Jul 01, 2020 |
|
COVID-19 Impact on people with lupus
|
Jun 04, 2020 |
|
Lupus, immunity and Covid-19 - Part 2
|
Apr 12, 2020 |
|
Immunity for lupus patients and effects of Covid-19 - Part 1
|
Apr 08, 2020 |
|
Education and the latest in treatment: reporting from the Lupus Academy 2017
|
Jun 06, 2017 |
|
Lupus Science and Medicine first year anniversary
|
May 22, 2015 |
|
BMJ and the Lupus Foundation of America announce the first open access lupus scientific journal
|
Oct 23, 2013 |
|
What to expect from Lupus Science and Medicine
|
Oct 23, 2013 |